Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by LaserStock29on May 15, 2020 4:40pm

152 Views

Post# 31035896

RE:RE:RE:RE:RE:RE:SRNE - Sorrento Therapeutics Inc.

Message received. Let's see what the IND value is.

goldn1 wrote:
laser: Imo, at the end of the day, all that matters is patient data. If the PH2 shows 90% CR and no negative side effects, the stock will take off and IND will happen. If the results are mediocre, IND doesn't really matter as tlt won't have the goods to replace the current standard of care. Some on this board think it is a given that the PH2 will replicate patient 5 and 6 results, but with the stock being in the 20's, that seems like a stretch. IND doesn't mean the treatment works, results do... G1

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario